Annual screening strategies in <i>BRCA1</i> and <i>BRCA2</i> gene mutation carriers

Abstract

Annual MRI at age 25 years/delayed alternating DM at age 30 years is probably the most effective screening strategy in BRCA mutation carriers. Screening benefits, associated risks, and personal acceptance of false-positive results should be considered in choosing the optimal screening strategy for individual women.